sonefpeglutide

News

Eli Lilly's relentless pipeline-building drive has continued with a licensing deal for Hanmi's sonefpeglutide, in phase 2 for short bowel syndrome.

News

Millions of women with a breast cancer diagnosis could safely avoid chemotherapy that would not be effective, thanks to a genomics test.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.